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Abstract: Chemical and biochemical modification of hydro-
gels is one strategy to create physiological constructs that
maintain cell function. The aim of this study was to apply
oxidised alginate hydrogels as a basis for development of a
biomimetic niche for limbal epithelial stem cells that may be
applied to treating corneal dysfunction. The stem phenotype
of bovine limbal epithelial cells (LEC) and the viability of cor-
neal epithelial cells (CEC) were examined in oxidised alginate
gels containing collagen IV over a 3-day culture period. Oxi-
dation increased cell viability (P0.05) and this improved fur-
ther with addition of collagen IV (P0.01). Oxidised gels
presented larger internal pores (diameter: 0.2–0.8 mm) than
unmodified gels (pore diameter: 0.05–0.1 mm) and were sig-
nificantly less stiff (P0.001), indicating that an increase in
pore size and a decrease in stiffness contributed to improved
cell viability. The diffusion of collagen IV from oxidised alginate
gels was similar to that of unmodified gels suggesting that oxi-
dation may not affect the retention of extracellular matrix pro-
teins in alginate gels. These data demonstrate that oxidised
alginate gels containing corneal extracellular matrix proteins
can influence corneal epithelial cell function in a manner that
may impact beneficially on corneal wound healing therapy.
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INTRODUCTION
Limbal epithelial stem cells (LESC) are one of a small group
of progenitor cells that are currently applied as a successful
clinical therapy. LESC are resident adult stem cells in the
outer edge of the cornea that terminally differentiate into
limbal epithelial cells (LEC), which migrate across the ocular
surface ﬁnally forming the uppermost layer of the cornea
before desquamation. These cells, particularly when sup-
ported upon amniotic membrane (AM) scaffolds, can reverse
corneal blindness caused by limbal stem cell deﬁciency
(LSCD).1–3 A key issue associated with the therapeutic use
of LESC, however, is the variation in clinical outcomes
following their transplantation, due to differences in the
severity of injuries from patient to patient. Another problem
is that the AM scaffold is heterogeneous in structure and
this affects LESC culture.2,4,5 AM preparation is also time-
consuming and involves serological screening to monitor
the risk of viral transmission.
These problems may be eliminated through the reﬁne-
ment of existing LSCD therapy by using structurally modi-
ﬁed biomaterials to deliver LESC.6 Advantages of
biomaterials include structural uniformity and malleability,
predictable degradation, and the ability to direct stem cell
fate. These matrices can, therefore, allow a number of differ-
ent strategies to address variations in the severity of
corneal injuries, including delivery of greater numbers of
LESC to the cornea, more efﬁcient maintenance of the LESC
phenotype, and delivery of LESC-derived biomolecules.7
Native biomaterial constructs are not sufﬁcient to maintain
the physiological functions and phenotype of cells as they
do not present a normal in vivo environment. These matri-
ces often require biophysical (e.g., increasing internal pore
size, decreasing compressive modulus/stiffness) and bio-
chemical (e.g., cell adhesion peptide motifs, extracellular
matrix (ECM) proteins) modiﬁcations to present the cells
with conditions which support their ‘normal’ function.
Therefore, the addition of niche-like properties (e.g., inclu-
sion of ECM proteins or cell adhesion peptides and modiﬁ-
cation of porosity to mimic physiological micro ﬂuidic
features) into existing biomaterial structures is increasingly
employed. The aim of the present study was to investigate
oxidised alginate hydrogels containing the corneal basement
membrane ECM protein collagen IV, as matrices for the
encapsulation of corneal epithelial cells in order to begin
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construction of artiﬁcial niche-like environments applicable
to therapeutic delivery of these cells.
Alginate is well-established as a biocompatible material
for cell encapsulation8–10 and tissue transplantation,11,12 but
modiﬁcations to native alginate hydrogels to create gels that
mimic the physiological environment of encapsulated cells
are necessary to allow optimum cell viability and func-
tion.13,14 We have previously investigated alginate hydrogels
as substrates for storage/transport of LESC and LEC,8,9 and
found that increasing the porosity and decreasing the stiff-
ness of alginate gels increased the viability of encapsulated
cells.8 Other studies have shown that the viscoelastic15 and
physicochemical16 properties of alginate gels and their
chemical modiﬁcation (e.g., sulfation,17 oxidation18–24) can
direct cell function.
Oxidised alginate gels in particular were previously
demonstrated to be cyto-compatible for a number of cell
types including corneal endothelial cells,18 hepatocytes,19
ﬁbroblasts,20 mesenchymal stem cells,21 adipose stem
cells,22 and human osteo-progenitors.23 Studies have been
performed to investigate the use of oxidised alginate as a
wound healing scaffold.24,25 Oxidation of alginate affects
the swelling behavior, degradation proﬁle, and storage
modulus of the resultant gel, allowing these features to be
controlled depending on the degree of oxidation. It is these
properties that underpin the beneﬁcial wound healing
effects of alginate scaffolds.22,23 Predictable degradation of
alginate gels is an important structural feature that can
allow the controlled release of therapeutic biomolecules or
cells into damaged tissues. Tissue engineering strategies
are currently under investigation using degradable oxi-
dised alginate hydrogels—these matrices were shown to
greatly improve cartilage-like tissue formation in vivo23 as
well as the growth of adipose tissue from adipose stem
cells.22 The possibility of introducing proteins into oxi-
dised alginate gel systems to create an extracellular
matrix-like milieu has also been explored. Recent reports
have described oxidized RGD–alginate23,26 and oxidised
alginate crosslinked with gelatin as efﬁcient wound healing
scaffolds.24
In the present study we demonstrate that the viability of
both bovine primary and immortalised human corneal epi-
thelial cells [HCE: referred to as corneal epithelial cells
(CEC)] immobilized in alginate gels was enhanced by prior
oxidation of these matrices. We also show that incorporating
collagen IV, a key ECM protein in the corneal basement
membrane, into oxidised gels caused a further enhancement
in cell viability. We correlated increased viability to an
increase in porosity and a decrease in gel stiffness and
observed that these gels were able to support a population
of undifferentiated LEC. We conclude that oxidised alginate
gels containing limbal ECM proteins may be developed into
important tools for regeneration of the injured or dysfunc-
tional cornea. For example, a niche-like environment formed
from modiﬁed alginate gels containing LESC may allow
these cells to be engrafted without expansion, then to either
migrate from the gel or secrete factors that allow repair of
the damaged ocular surface.
MATERIALS AND METHODS
Materials
Dulbecco’s minimal essential medium (DMEM) and Ham’s
F12 medium (DMEM/F12,1:1), antibiotics (penicillin/strep-
tomycin), fetal bovine serum (FBS), amphotericin B, dime-
thylsulfoxide (DMSO), HCl, Whatman chromatography paper,
O.C.T (TissueTek) and Trypan blue were purchased from
Fisher Scientiﬁc (Leicestershire, UK). Human epidermal
growth factor (hEGF), insulin, sodium alginate (viscosity:
15–20 cP, 1% in H2O (lit.)), calcium chloride, 3-(4,5-dime-
thylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT rea-
gent), sodium citrate, sodium chloride, sodium periodate,
ethylene glycol, starch solution, potassium iodide, sodium
phosphate buffer and ethyl alcohol were from Sigma–Aldrich
(Poole, UK). The HCE cell-line (CEC) was from RIKEN BioRe-
source Center (Tsukuba, Ibaraki, Japan). Osmium tetroxide
was from Agar Scientiﬁc (Essex, UK). The enhanced chemi-
luminescence (ECL) detection system and modiﬁed Lowry
protein assay kit were obtained from Pierce (Thermo Fisher
Scientiﬁc; Rockford, IL). The 14-3-3f antibody (rabbit poly-
clonal, immunogen: human 14-3-3f peptide) was from Santa
Cruz Biotechnology (Autogen Bioclear UK, Calne, Wilts, UK),
the cytokeratin 3 (CK3: clone AE5—mouse monoclonal,
immunogen: rabbit corneal epithelial keratin) antibody was
purchased from Millipore (Dundee, Scotland) and the
cytokeratin 14 [CK14: guinea pig polyclonal, immunogen:
Recombinant human keratin K14 (complete polypeptide)]
antibody was from Progen Scientiﬁc (Merton, UK). Horse-
radish peroxidase (HRP)-conjugated secondary antibodies
(anti-mouse (1:8,000 dilution) and anti-guinea pig (1:10,000
dilution)) were from R and D systems (Abingdon, UK) and
bovine serum albumin (BSA) was obtained from First Link
(Birmingham, UK).
Methods
Oxidation of alginate. A 1% (w/v) solution of sodium
alginate (8.0 g, 40.4 mmol uronate) in distilled water was
mixed with an aqueous solution of sodium periodate
(0.25M, 2.0 mmol) and incubated at room temperature for
24 h, after which the reaction was quenched by the addition
of an equimolar amount of ethylene glycol. Sodium chloride
(20 g) was then added to the solution, followed by precipi-
tation with 2 excess volumes of ethyl alcohol (1.6 L). The
precipitates, collected by centrifugation, were redissolved in
distilled water (0.8 L) and precipitated again with ethyl
alcohol (1.6 L). The resulting oxidized alginate was freeze-
dried (Manufacturer: Thermo Scientiﬁc, Model: MicroModu-
lyo 230) under reduced pressure to yield a white solid
(7.2 g, 90% yield).
Determination of degree of oxidation. The degree of algi-
nate oxidation was determined by measuring the percentage
of sodium periodate consumed before the reaction was
quenched with ethylene glycol. The consumption of sodium
periodate was monitored spectrophotometrically using
starch as an indicator. Brieﬂy, equal volumes of freshly pre-
pared potassium iodide solution (20% (w/v), pH 7.0
sodium phosphate buffer) and starch solution (10% (w/v),
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pH 7.0 sodium phosphate buffer) were mixed and immedi-
ately reacted with a solution of the oxidized alginate at
room temperature. The concentration of the unreacted peri-
odate was measured spectrophotometrically at 486 nm and
this value was used to determine the amount of periodate
consumed.
Determination of the molecular weight of oxidised
alginate by size exclusion chromatography. Average
molecular weights were determined by gel permeation chro-
matography using a Shimadzu HPLC system with RID-10A
refractive index detector and SEC TSK G3000PW and
G4000PWxl columns (Phenomenex, Mcclesﬁeld, Cheshire
UK). Samples were run at 27C in ultrapure water.
Isolation of limbal epithelial cells from the cornea. The
established bovine cornea model4,27,28 was used for the iso-
lation of limbal epithelial cells (LEC). Normal bovine eyes
were obtained from a local abattoir (Chitty Wholesale abat-
toir, Guildford, UK) within 2 h of death, transported to the
laboratory at 4C and used immediately. Corneoscleral rims
were dissected using standard eye bank techniques, as pre-
viously described.4,27,28 Primary LEC were not cultured
prior to encapsulation in alginate gels, they were encapsu-
lated immediately following isolation; these cells were
incorporated in this study to examine the effect of alginate
oxidation on their progenitor phenotype.
Culture of corneal epithelial cells. A human corneal epithe-
lial cell-line29 (CEC) was cultured in DMEM/F12, 1:1 supple-
mented with 5% (v/v) FBS, 0.5% (v/v) DMSO, 10 ng mL21
hEGF, 5 mg mL21 insulin, 100 IU mL21 penicillin and 100
mg mL21 streptomycin, at 37C under 5% CO2 and 95%
humidity. Cells were replenished with fresh medium every 3
days and grown to 70–80% conﬂuency before encapsulation
in calcium alginate gel discs. CEC were used in the present
study as proof of concept to determine the biocompatibility
of oxidised alginate gels for these corneal cells.
Encapsulation of CEC and LEC in calcium alginate gel
discs. CEC or primary LEC (3 3 105 cells) were suspended
in 1.2% (w/v) sodium alginate solution with or without
collagen IV (1 mg mL21) before gelling into discs6 using
102 mM CaCl2. To form gel discs, a paper ring with a 2 cm
diameter opening was placed over a 3 cm diameter paper
disc, and saturated with 102 mM CaCl2 before unmodiﬁed
or oxidised alginate solution (420 mL) was pipetted into the
ring. A second 3-cm diameter paper disc saturated with
102 mM CaCl2 was placed over the alginate/paper assembly.
Alginate solutions were exposed to 102 mM CaCl2 for 10 min
to allow complete gelation. Calcium alginate discs with
or without cells were suspended in DMEM/F12 medium
under cell culture (37C, 5% CO2, 95% humidity) conditions
for 3 days. Cells were extracted from gel discs using alginate
dissolving buffer (0.15M NaCl, 0.055M sodium citrate).
Cell viability analysis. The Trypan blue exclusion assay
was performed by mixing a 10 mL cell suspension with
10 mL Trypan blue dye solution, before counting live
(unstained) and dead (stained-blue) cells using a
haemocytometer.
Immunoblotting. Sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS-PAGE) was carried out in discontin-
uous vertical slab gels which contained a ﬁnal concentration
of 15% v/v acrylamide in the resolving gel and 4% (v/v)
acrylamide in the stacking gel. The stacking gel contained
stacking gel buffer (0.5M Tris-base; pH 6.8), 30% (v/v)
acrylamide, 10% (w/v) SDS, 0.05% (v/v) TEMED and 1.5%
(w/v) AMPS. The resolving gel comprised resolving gel
buffer (3M Tris-base and 5N HCl; pH 8.8), 30% (v/v) acryl-
amide, 10% (w/v) SDS, 0.08% (v/v) TEMED and 1.5% (w/v)
AMPS. The amount of total protein in LESC lysates and CM
samples was quantiﬁed using the modiﬁed Lowry protein
assay, and samples were prepared by addition of an equal
volume of Laemmli reducing sample-treatment buffer (RSTB:
4% (w/v) SDS, 10% (v/v) 2-mercaptoethanol, 20% (v/v)
glycerol, 0.5 M Tris-base and 0.001% (w/v) bromophenol
blue) to solutions of lysed cells and CM (1:1). RSTB-treated
samples (10 mg total protein per sample) were loaded onto
the stacking gel and separated in resolving gels using 100 V
per gel. Gels were then immunoblotted.
Proteins were transferred from SDS-PAGE gels to PVDF
membranes under semidry conditions using 200 V per gel
for 2 h. Nonspeciﬁc binding to membranes was blocked by
incubation with 5% (w/v) bovine serum albumin (BSA) dis-
solved in 13 TBS-T (20 mM Tris-base, 0.14M NaCl, 0.1%
TweenVR -20; pH 7.6) for 1 h at room temperature. Mem-
branes were incubated with primary antibodies (anti-CK14
(1:8000 dilution) and anti-CK3 (1:4000 dilution)) diluted in
2% (w/v) BSA dissolved in 13 TBS-T at 4C overnight. Blots
were washed for 45 min in 13 TBS-T before incubation
with HRP-conjugated secondary antibodies (anti-mouse
(1:8000 dilution) and anti-guinea pig (1:10,000 dilution))
for 2 h at room temperature (RT) with rotation. Proteins
were detected on X-ray ﬁlm using an ECL system; the ﬁlm
was exposed to membranes for 5–10 s to capture protein/
ECL signals. CK14 and CK3 expression were detected and
blots were stripped (incubation with 2% (w/v) SDS, 5%
(v/v) 2-mercaptoethanol in 13 TBS-T at 80C for 20 min)
to remove primary and secondary antibodies, before their
total levels were measured using anti-14-3-3f antibody
(loading control–1:4000 dilution) using the same X-ray ﬁlm
and ECL system. 14-3-3f was used as the loading control as
it is a protein of low variability comparable to the com-
monly used loading control GAPDH; we found that GAPDH
was difﬁcult to detect clearly in bovine LEC using commer-
cially available antibodies.
Collagen IV diffusion from oxidised alginate gels. Collagen
IV deposition from oxidised and unmodiﬁed alginate gel
spheres was measured. Gel spheres were prepared by
mixing 1 mg collagen IV into 1 mL alginate solution (ﬁnal
concentration: 1.2% (w/v)), before using a peristaltic pump
to dispense alginate solution dropwise into a 102 mM CaCl2
bath for 10 min. Gels were agitated at 20 rpm and 37C
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and the amount of total protein in degraded gel material
was quantiﬁed using the modiﬁed Lowry protein assay.
Scanning electron microscopy (SEM) analysis of oxidised
alginate gel structure. The internal surfaces of calcium
alginate and oxidised calcium alginate gels were examined
by SEM. Gels were ﬁxed in 1.25% (v/v) glutaraldehyde and
post-ﬁxed for 2 h in 1% (v/v) aqueous osmium tetroxide,
after which they were washed in distilled water and passed
through a graded ethanol series (50, 70, 90, and 100%
(v/v)) before dehydration through critical point drying.
Dehydrated gels were fractured to expose internal surfaces,
mounted on aluminum stubs and sputter coated with gold
before examination using SEM (FEI Quanta FEG 600, UK).
Rheological measurements
Gel spheres were formed by dispensing 2 mL alginate solu-
tions dropwise into 30 mL CaCl2 (102 mM). Mechanical
testing of gels was achieved by compressing these struc-
tures using a TA.XTplus Texture Analyser (Stable Micro
Systems, Surrey, UK) with a 5-kg load cell and a P/1KS ﬂat
ended stainless steel probe (Stable Micro Systems, Surrey,
UK) with a 1 cm2 surface area. Measurement of the force
was taken, with a trigger force of 0.0005 N, and the yield
point of gel spheres (point at which the gels split) was
recorded. Force was recorded as the mechanical limit of the
gels, described as comparative yield force and 10 measure-
ments of each gel sample were performed.
Statistical analysis
Unpaired t tests were performed using Microsoft Excel.
Results are presented as the mean of three individual exper-
iments6 standard error of the mean (S.E.M.), with P value
< 0.05 considered signiﬁcant.
RESULTS AND DISCUSSION
Formation and structural characterization of oxidised
alginate
Alginate was partially oxidized (Fig. 1) to a theoretical
extent of 2%, and 5% with sodium periodate following a
modiﬁed procedure as previously reported.30 Oxidation was
assessed by measuring levels of sodium periodate after the
oxidation reaction. Sodium periodate levels were negligible,
indicating that the alginate structure was oxidised.31
The average molecular weights (MWs) of native and oxi-
dised alginate were determined using size exclusion chroma-
tography; the MW of 2% oxidised alginate was similar to that
of native alginate (99 kDa), while that of 5% oxidised alginate
was 68 kDa as would be expected from a more extensive
cleavage of the alginate backbone. The extent of oxidation
was inversely related to the hydration of the gels (Table I)
prepared at the same weight per volume (1.2% w/v) of the
native alginate gels; 5% oxidised alginate was signiﬁcantly
(P 0.05) more hydrated than unmodiﬁed gels.
The increase in hydration of oxidised alginate-based gels
has been previously described. An in situ forming hydrogel
wound dressing formulated from an oxidised alginate and
gelatin matrix, crosslinked together in the presence of
borax, was found to have a ﬂuid uptake of 90% of its
weight.24 This hydrogel was demonstrated to maintain a
moist environment over skin wounds whilst absorbing
accumulating exudates; the wound bed covered with the
hydrogel was ﬁlled with epithelium within 2 weeks.
Re-epithelialization of the ocular surface is an essential pro-
cess in corneal wound healing, and hydration is a critical
factor for a healthy, functioning cornea. Therefore, oxidised
alginate gels may serve as viable wound healing bandages
for the damaged cornea that allows for hydration of the
corneal surface whilst simultaneously providing an environ-
ment for re-epithelialization.
Corneal epithelial cell viability and phenotype in
oxidised alginate gels
In the present study we have begun investigating the possi-
bility that alginate gels are suitable for the development of
an artiﬁcial LEC niche construct. We assessed the impact of
oxidation-induced changes in alginate structure, as well as
incorporation of collagen IV, on the viability of corneal
epithelial cells and the stem phenotype of limbal epithelial
stem cells within these chemically modiﬁed matrices.
We observed that modiﬁcation of alginate gels by oxida-
tion (5%) caused a signiﬁcant increase (P< 0.05) in corneal
epithelial cell viability, and the addition of collagen IV into
FIGURE 1. The reaction scheme for oxidation of alginate by sodium
periodate.
TABLE I. The Hydration and Stiffness of Unmodified
and Oxidized Alginate Gels
Gel type
Mean Hydra-
tion (6 S.E.M.)
Mean Compressive
Modulus (6 S.E.M.)
1.2% (w/v) calcium
alginate
2.846 0.10 147.0261.11
2% oxidised 1.2% (w/v)
calcium alginate
3.286 0.24 141.2160.59
5% oxidised 1.2% (w/v)
calcium alginate
3.346 0.22 115.1762.18
Data points represent at least 3 (6 S.E.M.) individual measurements
of dry and wet weights of gels used to calculate hydration. Data
points for compressive moduli (stiffness) represent 10 (6 S.E.M.) indi-
vidual measurements.
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5% oxidised gels further increased cell viability (P<0.01)
(Fig. 2). LEC differentiation (cytokeratin 3–marker of differ-
entiation) in unmodiﬁed and oxidised alginate gels was not
signiﬁcantly different (Fig. 3). Although the marker for
undifferentiated LEC, cytokeratin 14 (CK14), was expressed
in oxidised gels, expression levels were not signiﬁcantly
different between unmodiﬁed and oxidised gels. Therefore,
oxidised alginate gels may drive the differentiation of
progenitor limbal epithelial cells to the same extent as
unmodiﬁed alginate.
The 2% oxidised alginate supported cell viability to a sim-
ilar extent as unmodiﬁed alginate, but presented a similar
internal pore size (pore diameter: 0.05–0.1 mm) (Fig. 4) and
was signiﬁcantly less stiff than the unmodiﬁed gel (P 0.001)
(Table I). By contrast, a signiﬁcantly greater proportion of the
cells encapsulated in 5% oxidised alginate were viable
compared to those in unmodiﬁed alginate gels, and the 5%
oxidised gel displayed internal pores with wider diameters
(0.2–0.8 mm), and signiﬁcantly lower stiffness than unmodi-
ﬁed alginate. It is likely that the metabolic activity and viabil-
ity of corneal epithelial cells released from oxidised alginate
gels correlate, as we have previously reported similar results
with unmodiﬁed alginate gels.8 We have also shown that live
epithelial cells (viability assessed by Trypan blue exclusion)
released from alginate gels are able to grow and form into
colonies.8 This indicates that live cells released from oxidised
alginate gels remain functional. In our reported studies some
alginate gels allowed 100% recovery of encapsulated live
cells.8 Therefore it is possible that as full recovery of encapsu-
lated live cells was not achieved in the present study, a popu-
lation of those cells underwent apoptosis. These data indicate
that increased pore size conferred by oxidation is a greater
determinant of the increase in cell viability, than decreased
stiffness.
We also investigated the diffusion of collagen IV from
oxidised alginate gels, to begin examining the potential
FIGURE 2. Modification of alginate through oxidation and incorpora-
tion of collagen IV enhance the viability of encapsulated corneal epi-
thelial cells. Data points represent the mean number of live cells
extracted6S.E.M (n53). *(P< 0.05) and **(P< 0.01) indicate differen-
ces between culture conditions.
FIGURE 3. LESC differentiate in oxidised calcium alginate gels. CK14
(A) and CK3 (B) were detected in freshly isolated LEC (control: C) and
LEC cultured for 3 days in unmodified and 2 or 5% oxidised alginate
gel discs under cell culture conditions by immunoblotting. The
14-3-3f was used as a loading control. Blots represent three individual
experiments from three different corneoscleral rims.
FIGURE 4. Internal pores in oxidised and unmodified calcium alginate gels. Unmodified (A) and 2% (B) and 5% (C) oxidised calcium alginate
HEC gel discs were dehydrated and internal surfaces were examined using SEM. Electron micrographs (350,000 magnification) are representa-
tive of three individual experiments.
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stability of these constructs under physiological conditions.
The concentration of collagen IV lost from 5% oxidised algi-
nate gels was signiﬁcantly greater after 48 h than 24 h, but
there was no difference in protein loss compared to
unmodiﬁed gels at either time point (Table II). Our data
suggest that ECM molecules may become entrapped within
alginate gels or, in the case of oxidized alginate, there is the
potential of covalent incorporation of the protein by reac-
tion of a free amine with aldehydes in the alginate. It is
unlikely that collagen IV has become covalently bound to
oxidised alginate in the present study as the concentration
of protein released is similar between oxidised and
unmodiﬁed alginate.
Previous studies describe cell viability proﬁles in
oxidised alginate gels that are in line with our ﬁndings.
Hepatocytes encapsulated in periodate-oxidised alginate
(containing crosslinked gelatin in the presence of sodium
tetraborate), maintained their characteristic morphology
after 4 weeks in this matrix.19 These cells also remained
functional, retaining their albumin producing ability for up
to 2 weeks following encapsulation. Oxidised and RGD-
grafted alginate microspheres loaded with human osteopro-
genitors from bone marrow mesenchymal stem cells with
or without human umbilical vein endothelial cells increased
mineralization within bone defects in animal models.23
NH3T3 ﬁbroblasts immobilized in a composite N,O-carboxy-
methyl chitosan/oxidized alginate hydrogel were shown to
spread and grow inside this gel.20 A similar composite gel
based on hydroxypropyl chitosan and periodate-oxidised
sodium alginate dialdehyde was reported as a potential
scaffold for reconstruction of the corneal endothelium.18
Corneal endothelial cells encapsulated in the composite gel
system on Descemet’s membranes survived and retained
their normal morphology. Therefore, corneal tissue engi-
neering approaches may be taken using oxidised alginate
gels as a basis.
Certainly, these matrices have been used together
with human adipose stem cells (hADSC) and MSC for
engineering adipose22 and osteogenic tissue,21 respec-
tively. hADSC were differentiated into adipogenic cells
and encapsulated into alginate gels modiﬁed by partial
periodate oxidation.22 hADSC laden gels were subcutane-
ously injected into the chest wall of male nude mice.
Newly generated adipose tissue was produced after 10
weeks in all experimental mice. Oxidised alginate micro-
spheres were also shown to direct the differentiation of
MSC to osteogenic and adipogenic tissues.21 Encapsulated
MSC remained viable in vitro and both osteo-
differentiated and adipo-differentiated after 4 weeks of
culturing in induction media. Similarly, ﬁndings of the
present study show that LESC differentiate in oxidised
alginate gels.
Studies have also described oxidised alginate gels
containing proteins or peptide motifs for wound healing
applications.32,33 In the present study, we incorporated
collagen IV into alginate gels to investigate the effect of
ECM proteins in addition to oxidation on the viability of
encapsulated cells. Periodate-oxidised alginate rapidly cross-
links proteins (e.g., gelatin) in the presence of borax (tetra-
sodium borate) to produce in situ forming hydrogels that
are biocompatible and biodegradable. These hydrogels were
demonstrated as efﬁcient wound healing dressings on full
thickness wounds in a rat model; within 2 weeks of applica-
tion the wound covered with gel was completely ﬁlled with
new epithelium.24 Periodate-oxidised alginate/gelatin
wound dressings have also been applied for the delivery of
molecules that promote wound healing. Dibutyryl cyclic
adenosine monophosphate (DBcAMP), a lipophilic analog of
cAMP was incorporated into this gel construct.33 Evaluation
of the efﬁcacy of the dressing on full thickness wounds
demonstrated complete re-epithelialization of the wound
within 10 days. Re-epithelialization of the cornea may be
possible using in situ formed oxidised alginate gels contain-
ing gelatin.
In the present study, we hypothesize that the differen-
ces in viability observed between native and oxidised
alginate gels may be due to increased porosity caused by
oxidation-induced changes in gel mass, as we have previ-
ously reported that increasing the porosity of alginate
gels increases the viability of encapsulated CEC.8 We
observed that the porosity of oxidised gels is greater than
that of native gels, and that gel stiffness decreases with
increases in the extent of oxidation. We associated the
degree of oxidation, porosity and stiffness to a discrete
level of cell viability. It may be possible to investigate the
effect of alginate gel stiffness on the phenotype and via-
bility of encapsulated LEC. Alginate has a backbone of
rigid a-L-guluronate and more ﬂexible b-D-mannuronate;
the chain stiffness and steric hindrance of polyguluronate
molecules from alginate can be regulated by partial oxi-
dation.34 The signiﬁcantly reduced stiffness we measured
is likely due to chemical oxidation and a lowering of
molecular weight.
The stiffness of oxidised alginate gels is an important
property of these gels that is currently being exploited in
the biomedical ﬁeld. Biodegradable, partially crosslinked
alginate scaffolds with shape-memory properties were pre-
viously fabricated for minimally invasive surgical
TABLE II. Diffusion of Collagen IV from Oxidised Alginate
Gels
Gel Type
Concentration of
Diffused Collagen
IV (mg mL21) (6 S.E.M.)
1.2% (w/v) calcium
alginate1 collagen IV – 24 h
177.426 0.010
5% oxidised 1.2%
(w/v) calcium alginate1
collagen IV – 24 h
177.426 0.008
1.2% (w/v) calcium
alginate1 collagen IV – 48 h
594.876 0.006
5% oxidised 1.2% (w/v)
calcium alginate1 collagen IV – 48 h
599.046 0.009
Data represent the mean6S.E.M. amount (mg mL21) of collagen IV
protein released from unmodified and 5% oxidised calcium alginate
gels (n5 3).
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applications. These were constructed by mixing together
high and low molecular weight partially oxidized alginate
modiﬁed with RGD peptides and performing covalent cross-
linking using carbodiimide chemistry. The resulting scaffold
was compressible 11-fold and returned to its original shape
when rehydrated.35 Other studies demonstrated in situ gel-
able hydrogels based on oxidised alginate and gelatin36 or
teleostean37 with elastic moduli that can be controlled by
adjusting the oxidation degree of alginate and the weight
ratio of gelatin and teleostean.
Another important physical property conferred by oxida-
tion is the controlled degradation of alginate gels; alginate
gels tend to disintegrate in electrolyte solutions. Alginate
oxidised to a low degree (5%), was reported to degrade at
a rate dependent on pH and temperature—the gel degraded
within 9 days in PBS solution.30 Interestingly, studies have
shown that the degradation of oxidised alginate can be
regulated. Poly(acrylamide-co-hydrazide) (PAH), a multi-
functional crosslinking molecule, or adipic acid dihydrazide
(AAD), a bi-functional crosslinking molecule, were used to
crosslink oxidised alginate gels.38 PAG/PAH hydrogels
showed higher mechanical stiffness before degradation and
degraded more slowly than PAG/AAD gels, at the same con-
centration of crosslinking functional groups. The enhanced
mechanical stiffness and prolonged degradation behavior
could be attributed to the multiple attachment points of
PAH in the gel at the same concentration of functional
groups. Another method for controlling alginate gel degrada-
tion employed methacrylation that changes uronate residue
conformations to an open chain adduct, making them more
vulnerable to hydrolysis.39 This modiﬁcation allows the deg-
radation proﬁles of alginate matrices to be tunable by the
degree of oxidation.
Taken together, we conclude that the ﬁndings of the
present study describe novel avenues for the culture of LEC
that can form the foundation of alginate-based niche con-
structs focusing on chemical oxidation and incorporation of
corneal ECM proteins.
CONCLUSIONS
Our study concludes that corneal epithelial cells can be
maintained in porous, low modulus, oxidised alginate gels
containing collagen IV, with predictable diffusion rates for
ECM proteins in physiological environments. Oxidation of
alginate gels may be employed as a means to control the
mass transfer of biomolecules from immobilized cells whilst
allowing controlled degradation of these scaffolds to release
therapeutic cells. This may be an important future develop-
ment in the use of alginate constructs for corneal cell deliv-
ery and culture. Therapy for LSCD may be reﬁned (i.e.,
variability in treatment outcomes could be eliminated),
through the use of these multi-functional hydrogel niche-
like devices. The degree of oxidation may even be tuned to
control corneal cell function and LESC fate. We have
acquired initial components of a toolbox that will allow con-
trol of individual aspects of LESC function, by altering physi-
cal properties of gels used to immobilize these cells before
their therapeutic delivery.
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